Friday, 29/08/2008
You are here:
Home
: Products
: Licensed Products
: HGSI
HGSI
| LymphoStat-B™ | HGS-ETR1 | HGS-ETR2 | ABthrax™ | |
In 1999/2000 CAT entered into two research agreements with Human Genome Sciences Inc (HGSI) from which four human monoclonal antibody drug candidates are now in clinical development.
| Partners | Product | Target | Disease | PreC | PhI | PhII | PhIII | Fld | Mkt |
|---|---|---|---|---|---|---|---|---|---|
| HGSI | LymphoStat-B™ | BLyS | systemic lupus erythematosus | ||||||
| HGSI | LymphoStat-B™ | BLyS | rheumatoid arthritis | ||||||
| HGSI | HGS-ETR1 | TRAIL-R1 | non small-cell lung cancer | ||||||
| HGSI | HGS-ETR1 | TRAIL-R1 | non Hodgkin's lymphoma | ||||||
| HGSI | HGS-ETR1 | TRAIL-R1 | advanced colorectal cancer | ||||||
| HGSI | HGS-ETR1 | TRAIL-R1 | myeloma (+chemotherapy) | ||||||
| HGSI | HGS-ETR1 | TRAIL-R1 | solid tumours (+ chemotherapy) | ||||||
| HGSI | HGS-ETR1 | TRAIL-R1 | advanced solid tumours | ||||||
| HGSI | HGS-ETR2 | TRAIL-R2 | advanced solid tumours | ||||||
| HGSI | ABthrax™ | b.anthracis | anthrax infection |
© 2008 MedImmune Limited | Disclaimer